Bioactive Compounds
-
B5599 Fatostatin ASummary: sterol regulatory element binding protein (SREBP) inhibitor -
B5601 Ceranib 1Summary: ceramidase inhibitor -
B5603 YE 120Summary: GPR35 agonist -
B5635 T16Ainh - A01Summary: inhibitor of Ca2+-dependent Cl- channel (CaCC) transmembrane protein 16A (TMEM16A) -
B5636 CS 2100Summary: S1P1 agonist -
B5658 MK 1903Summary: hydroxycarboxylic acid receptor 2 (HCA2, GPR109A) full agonist -
B5733 HJC 0350Summary: EPAC2 antagonist, potent and selective -
B8009 UNC0379Summary: N-lysine methyltransferase SETD8 inhibitor -
B8010 NIBR189Summary: EBI2 (GPR183) receptor antagonist -
A1039 Amyloid Beta-peptide (25-35) (human)3 CitationSummary: β-amyloid peptide fragment; for Alzheimer’s disease-related neurotoxicity models

